Translation of remote ischaemic preconditioning into clinical practice.
Reduction of the burden of ischaemia-reperfusion injury is the aim of most treatments for cardiovascular and cerebrovascular disease. Although many strategies have proven benefit in the experimental arena, few have translated to clinical practice. Scientific and practical reasons might explain this...
Κύριοι συγγραφείς: | Kharbanda, R, Nielsen, T, Redington, A |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2009
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
BETA-CATENIN PATHWAY EXPRESSION IN HUMAN MYOCARDIUM IS INCREASED BY A REMOTE ISCHAEMIC PRECONDITIONING STIMULUS
ανά: Contractor, H, κ.ά.
Έκδοση: (2009) -
Increased Beta-Catenin Pathway Expression by a Remote Ischaemic Preconditioning Stimulus: First Evidence in Humans
ανά: Contractor, H, κ.ά.
Έκδοση: (2009) -
ADENOSINE RECEPTOR INHIBITION ABOLISHES REMOTE ISCHAEMIC PRECONDITIONING IN HUMANS
ανά: Contractor, H, κ.ά.
Έκδοση: (2009) -
Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study.
ανά: Kharbanda, R, κ.ά.
Έκδοση: (2006) -
Remote ischaemic preconditioning (rIPC) reduces cardiac and pulmonary dysfunction following experimental cardiopulmonary bypass
ανά: Kharbanda, R, κ.ά.
Έκδοση: (2004)